Concepedia

Ian Lai

IL

Statistics

Publications

8

Citations

490

H-Index

8

Active since

2017

Affiliations

Stanford University(Current)

Yale Cancer Center

NRG Oncology

Universidad de Granada

Chan Zuckerberg Initiative (United States)

Ian Lai is an author at Stanford University specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2017–2025

8

Publications

8

Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma

Ian Lai, Srividya Swaminathan, Virginie Baylot et al. · Journal for ImmunoTherapy of Cancer · 2018 · 148 citations · Full text

, , +17

<i>Tahoe-100M</i> : A Giga-Scale Single-Cell Perturbation Atlas for Context-Dependent Gene Function and Cellular Modeling

Jesse Zhang, Airol A Ubas, Richard de Borja et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2025 · 82 citations · Full text

, , +14

MYC and Twist1 cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunity

Renumathy Dhanasekaran, Virginie Baylot, Minsoon Kim et al. · eLife · 2020 · 73 citations · Full text

, , +17

MYC Overexpression Drives Immune Evasion in Hepatocellular Carcinoma That Is Reversible through Restoration of Proinflammatory Macrophages

Renumathy Dhanasekaran, Aida S. Hansen, Jangho Park et al. · Cancer Research · 2022 · 56 citations · Full text

, , +17

Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC)

Renumathy Dhanasekaran, Meital Gabay-Ryan, Virginie Baylot et al. · Oncotarget · 2017 · 45 citations · Full text

, , +17

1–5 of 8